Cytokine networks in glioma
- PMID: 21656131
- DOI: 10.1007/s10143-011-0320-y
Cytokine networks in glioma
Abstract
Glioma is the most frequently occurring brain tumor, but the prognosis of patients with gliomas remains poor despite advances in surgery, radiotherapy, and chemotherapy. Therefore, great efforts have been made to develop improved therapeutic strategies. Cytokines are a heterogeneous group of soluble small polypeptides or glycoproteins that exert pleiotropic and redundant effects that promote the growth, differentiation, and activation of normal cells. Cytokines have either pro- or anti-inflammatory activity and immunosuppressive activity, depending on the microenvironment surrounding the tumor. The microenvironment consists of heterogeneous tumor cells, immune cells, and extracellular matrix. Modulation of the microenvironment by the tumor is essential for its growth and progress. Cytokine production acts as a means of communication in the tumor microenvironment. In this article, we review the cross-talk between cytokines in the tumor microenvironment and the cytokine therapies that have been used till date for glioma treatment.
Similar articles
-
Cytokine therapy.Adv Exp Med Biol. 2012;746:86-94. doi: 10.1007/978-1-4614-3146-6_7. Adv Exp Med Biol. 2012. PMID: 22639161 Review.
-
Cytokine Therapy of Gliomas.Prog Neurol Surg. 2018;32:79-89. doi: 10.1159/000469682. Epub 2018 Jul 10. Prog Neurol Surg. 2018. PMID: 29990976 Review.
-
Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle.Biochim Biophys Acta. 2014 Dec;1846(2):560-75. doi: 10.1016/j.bbcan.2014.10.003. Epub 2014 Oct 20. Biochim Biophys Acta. 2014. PMID: 25453365 Review.
-
Pro-inflammatory modification of cancer cells microsurroundings increases the survival rates for rats with low differentiated malignant glioma of brain.Int Rev Neurobiol. 2020;151:253-279. doi: 10.1016/bs.irn.2020.03.027. Epub 2020 May 13. Int Rev Neurobiol. 2020. PMID: 32448611
-
T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironment.J Neurooncol. 2020 Apr;147(2):281-295. doi: 10.1007/s11060-020-03450-7. Epub 2020 Mar 17. J Neurooncol. 2020. PMID: 32185647 Free PMC article. Review.
Cited by
-
miR-340-5p Suppresses Aggressiveness in Glioblastoma Multiforme by Targeting Bcl-w and Sox2.Mol Ther Nucleic Acids. 2019 Sep 6;17:245-255. doi: 10.1016/j.omtn.2019.05.022. Epub 2019 Jun 5. Mol Ther Nucleic Acids. 2019. PMID: 31272074 Free PMC article.
-
Regulation of Kir4.1 expression in astrocytes and astrocytic tumors: a role for interleukin-1 β.J Neuroinflammation. 2012 Dec 28;9:280. doi: 10.1186/1742-2094-9-280. J Neuroinflammation. 2012. PMID: 23270518 Free PMC article.
-
Organotypic brain slices: a model to study the neurovascular unit micro-environment in epilepsies.Fluids Barriers CNS. 2013 Feb 7;10(1):11. doi: 10.1186/2045-8118-10-11. Fluids Barriers CNS. 2013. PMID: 23391266 Free PMC article.
-
Immunosuppression in Gliomas via PD-1/PD-L1 Axis and Adenosine Pathway.Front Oncol. 2021 Feb 15;10:617385. doi: 10.3389/fonc.2020.617385. eCollection 2020. Front Oncol. 2021. PMID: 33659213 Free PMC article. Review.
-
Dysregulation of inflammasome activation in glioma.Cell Commun Signal. 2023 Sep 18;21(1):239. doi: 10.1186/s12964-023-01255-5. Cell Commun Signal. 2023. PMID: 37723542 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical